Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (21-30 of 565) with videos related to

Pageof 57
Sort By:
Cancer Biology & Medicine|November 4, 2014
Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyondNiki Karachaliou, Rafael Rosell
Nature Reviews. Clinical Oncology|December 24, 2014
Lung cancer in 2014: optimizing lung cancer treatment approachesRafael Rosell, Niki Karachaliou
The Lancet. Respiratory Medicine|July 19, 2018
Circulating tumour DNA genomics in EGFR-mutant lung adenocarcinomaRafael Rosell, Niki Karachaliou
Ebiomedicine|June 23, 2018
Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung CancerRafael Rosell, Niki Karachaliou
Molecular Oncology|May 10, 2021
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatmentMartyna Filipska, Rafael Rosell
The Lancet. Oncology|June 9, 2016
Trends in immunotherapy for brain metastasesRafael Rosell, Niki Karachaliou
The Lancet. Oncology|September 19, 2017
BRAF<sup>V600E</sup> and BRAF-inactivating mutations in NSCLCRafael Rosell, Niki Karachaliou
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeted treatment of mutated <i>EGFR</i>-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnosticsNiki Karachaliou, Rafael Rosell
Current Medicinal Chemistry|April 23, 2002
Neoadjuvant chemotherapy in non-small cell lung cancerEnriqueta Felip, Rafael Rosell
Translational Lung Cancer Research|March 14, 2018
An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs)Santiago Viteri, Rafael Rosell
Pageof 57

Showing results (21-30 of 565) with videos related to

Sort By:
Pageof 57
Cancer Biology & Medicine|November 4, 2014
Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyondNiki Karachaliou, Rafael Rosell
Nature Reviews. Clinical Oncology|December 24, 2014
Lung cancer in 2014: optimizing lung cancer treatment approachesRafael Rosell, Niki Karachaliou
The Lancet. Respiratory Medicine|July 19, 2018
Circulating tumour DNA genomics in EGFR-mutant lung adenocarcinomaRafael Rosell, Niki Karachaliou
Ebiomedicine|June 23, 2018
Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung CancerRafael Rosell, Niki Karachaliou
Molecular Oncology|May 10, 2021
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatmentMartyna Filipska, Rafael Rosell
The Lancet. Oncology|June 9, 2016
Trends in immunotherapy for brain metastasesRafael Rosell, Niki Karachaliou
The Lancet. Oncology|September 19, 2017
BRAF<sup>V600E</sup> and BRAF-inactivating mutations in NSCLCRafael Rosell, Niki Karachaliou
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeted treatment of mutated <i>EGFR</i>-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnosticsNiki Karachaliou, Rafael Rosell
Current Medicinal Chemistry|April 23, 2002
Neoadjuvant chemotherapy in non-small cell lung cancerEnriqueta Felip, Rafael Rosell
Translational Lung Cancer Research|March 14, 2018
An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs)Santiago Viteri, Rafael Rosell
Pageof 57